Dr Alistair Ring undertook his pre-clinical training at the University of Cambridge, clinical training at the University of Oxford and oncology training at The Royal Marsden NHS Foundation Trust. He then graduated from the Institute of Cancer Research, London, with an MD research degree in 2005.
In 2008, he moved to the Brighton and Sussex Medical School, where he was appointed as Senior Lecturer in Oncology and Director of the Brighton NIHR Clinical Research Facility.
Dr Ring was appointed Consultant Medical Oncologist at The Royal Marsden in 2014 and Honorary Reader in Breast Cancer Clinical Trials at the ICR in 2018. He is interested in all aspects of the medical treatment of breast cancer, with specialist interests in neo-adjuvant therapies, targeted therapies, and the treatment of advanced and metastatic disease.
He is Chair of the Committee for Clinical Research at the ICR and The Royal Marsden, and is a member of the National Cancer Research Institute (NCRI) Breast Clinical Studies Group. He is also a member of the American Society of Clinical Oncology (ASCO).
Dr Ring is Team Leader of the Breast Cancer Clinical Research Team.